InMed Pharmaceuticals is a biotechnology business based in the US. InMed Pharmaceuticals stocks (INM.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $2.92 – a decrease of 6.19% over the previous week. InMed Pharmaceuticals employs 0 staff and has a market cap (total outstanding stock value) of $16.3 million.
How to buy InMed Pharmaceuticals stock in Canada
- Choose a platform. If you're a beginner, our stock trading table below can help you choose.
- Open your account. You'll need your ID, bank details and national insurance number.
- Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
- Search the platform for stock code: INM in this case.
- Research InMed Pharmaceuticals stocks. The platform should provide the latest information available.
- Buy your InMed Pharmaceuticals stocks. It's that simple.
Is it a good time to buy InMed Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
What's in this guide?
- Can I buy shares in InMed Pharmaceuticals?
- InMed Pharmaceuticals shares summary
- Compare share dealing platforms
- Is InMed Pharmaceuticals stock a buy or sell?
- InMed Pharmaceuticals performance over time
- Can I short InMed Pharmaceuticals shares?
- InMed Pharmaceuticals's financials
- How volatile are InMed Pharmaceuticals shares?
- Does InMed Pharmaceuticals pay a dividend?
- Have InMed Pharmaceuticals shares ever split?
- Other common questions
InMed Pharmaceuticals stock priceUse our graph to track the performance of INM stocks over time.
InMed Pharmaceuticals stocks at a glance
|Latest market close||$1.82|
|52-week range||$1.76 - $5.661|
|50-day moving average||$2.1928|
|200-day moving average||$2.917|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-1.52|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
InMed Pharmaceuticals price performance over time
|1 week (2021-09-20)||-6.19%|
|1 month (2021-08-27)||-25.41%|
|3 months (2021-06-25)||-36.36%|
|6 months (2021-03-26)||-47.40%|
InMed Pharmaceuticals financials
|Gross profit TTM||USD$0|
|Return on assets TTM||-68.83%|
|Return on equity TTM||-150.84%|
|Market capitalisation||USD$16.3 million|
TTM: trailing 12 months
How to short and sell InMed Pharmaceuticals stocks
- Create a CFD or spread betting account.
- Search for the stock code. E.g. "INM.US"
- Choose your position size.
- Select "sell" rather than "buy".
- Confirm your position and keep tabs on it. You may wish to set limits on your position.
There are currently 23,132 InMed Pharmaceuticals stocks held short by investors – that's known as InMed Pharmaceuticals's "short interest". This figure is 216% up from 7,320 last month.
There are a few different ways that this level of interest in shorting InMed Pharmaceuticals stocks can be evaluated.
InMed Pharmaceuticals's "short interest ratio" (SIR)
InMed Pharmaceuticals's "short interest ratio" (SIR) is the quantity of InMed Pharmaceuticals stocks currently shorted divided by the average quantity of InMed Pharmaceuticals stocks traded daily (recently around 210290.90909091). InMed Pharmaceuticals's SIR currently stands at 0.11. In other words for every 100,000 InMed Pharmaceuticals stocks traded daily on the market, roughly 110 stocks are currently held short.
However InMed Pharmaceuticals's short interest can also be evaluated against the total number of InMed Pharmaceuticals stocks, or, against the total number of tradable InMed Pharmaceuticals stocks (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case InMed Pharmaceuticals's short interest could be expressed as 0% of the outstanding stocks (for every 100,000 InMed Pharmaceuticals stocks in existence, roughly 0 stocks are currently held short) or 0.0008% of the tradable stocks (for every 100,000 tradable InMed Pharmaceuticals stocks, roughly 1 stocks are currently held short).
Such a low SIR usually points to an optimistic outlook for the stock price, with fewer people currently willing to bet against InMed Pharmaceuticals.
Find out more about how you can short InMed Pharmaceuticals stock.
InMed Pharmaceuticals stock dividends
We're not expecting InMed Pharmaceuticals to pay a dividend over the next 12 months. However, you can browse other dividend-paying stocks in our guide.
Have InMed Pharmaceuticals stocks ever split?
InMed Pharmaceuticals stocks were split on a 1:33 basis on 6 July 2020. So if you had owned 33 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your InMed Pharmaceuticals stocks – just the quantity. However, indirectly, the new 3200% higher stock price could have impacted the market appetite for InMed Pharmaceuticals stocks which in turn could have impacted InMed Pharmaceuticals's stock price.
InMed Pharmaceuticals stock price volatility
Over the last 12 months, InMed Pharmaceuticals's stocks have ranged in value from as little as $1.76 up to $5.661. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a stocks volatility in relation to the market. The market (NASDAQ average) beta is 1, while InMed Pharmaceuticals's is 1.4116. This would suggest that InMed Pharmaceuticals's stocks are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
InMed Pharmaceuticals overview
InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company's lead product is INM-755, a cannabinol topical cream, which is in a second Phase I clinical trials for the treatment of epidermolysis bullosa. The company is also involved in developing INM-088, which is in preclinical studies for the treatment of glaucoma; and INM-405 for the treatment of orofacial pain. In addition, it engages in the development of cannabinoid-based treatments for various diseases, including dermatology and ocular diseases. Further, the company works on IND-enabling pharmacology and preclinical toxicology studies. It has a research collaboration agreement with BayMedica Inc. for the manufacturing and testing of novel cannabinoid therapeutics. The company was formerly known as Cannabis Technologies Inc. and changed its name to InMed Pharmaceuticals Inc. in October 2014. InMed Pharmaceuticals Inc. was incorporated in 1981 and is based in Vancouver, Canada.
Stocks similar to InMed Pharmaceuticals
InMed Pharmaceuticals in the news
InMed Pharmaceuticals : Reports Full Year Fiscal 2021 Financial Results and Provides Business Update
InMed Pharmaceuticals Inc. Releases FY 2021 Financial Report And Corporate Update
InMed Pharmaceuticals : Reports Full Year Fiscal 2021 Financial Results and Provides Business Update (Form 8-K)
Frequently asked questions
More on investing
Everything we know about the Cedar Realty Trust IPO, plus information on how to buy in. Read more…
We look at 6 popular stock discussion groups from Canada and overseas.Read more…
We’ve rounded up the top dividend stocks in Canada. Check out current stock prices, historical stock performance, company info and more.Read more…
More guides on Finder
How to buy Evergrande Group stock in Canada | $2.36
Steps to owning and managing China Evergrande Group shares from Canada.
How to buy Planet Labs (PL) stock in Canada when it goes public
Everything we know about the Planet Labs IPO, plus information on how to buy in.
How to buy Impossible Foods stock in Canada when it goes public
Everything we know about the Impossible Foods IPO, plus information on how to buy in.
How to buy Samsara stock in Canada when it goes public
Everything we know about the Samsara IPO, plus information on how to buy in.
How to buy Allbirds (BIRD) stock in Canada when it goes public
Everything we know about the Allbirds IPO, plus information on how to buy in.
How to buy Smooth Love Potion (SLP) in Canada
This guide will show you step-by-step instructions on how to buy the Smooth Love Potion (SLP) token as well as a list of exchanges you can trade it on.
How to buy OnlyFans stock in Canada when it goes public
Everything we know about the OnlyFans IPO, plus information on how to buy in.
How to buy Vinco Ventures stock in Canada | $6.32
Ever wondered how to buy shares in Vinco Ventures? We explain how and compare a range of providers that can give you access to many brands, including Vinco Ventures.
How to buy Weber stock in Canada | $15.41
Steps to owning and managing Weber Inc. stocks, with 24-hour and historical pricing before you buy.
How to buy Chobani stock in Canada when it goes public
Everything we know about the Chobani IPO, plus information on how to buy in.